miR-203amiR-3622b-5p:

Arezoo Azarian1, Samaneh Reiszadeh Jahromi2, Kiana Bahramzadeh1

  • 1Department of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran.

PubMed
概括

多发性硬化症 (MS) 的缺陷性亡与生存率 (BIRC5) 和IL-4的升高有关. 升级的miR-203a和miR-3622b-5p可能会推动这种情况,这表明MS的新治疗点.